- RecruitingPHASE1
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
This study is testing a new medicine, PIT565, for people with rheumatoid arthritis. We want to see if it's safe, how well the body handles it, and if it could help. It's an early stage study, focusing on finding the right dose.
For: Rheumatoid ArthritisArgentina · Bulgaria · China - Active not recruitingPHASE1
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
This study is testing a new medicine called PIT565 for people in the UK with certain types of blood cancer (B-cell Non-Hodgkin Lymphoma and B-cell Acute Lymphoblastic Leukaemia) that haven't responded well to previous treatments. It aims to find a safe dose and see how it works.
For: B-cell Non-Hodgkin Lymphoma (B-NHL) · B-cell Acute Lymphoblastic Leukemia (B-ALL)United States · Belgium · China - RecruitingPHASE1
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
This study is testing a new medicine called PIT565 for people with Systemic Lupus Erythematosus (SLE). It aims to see if PIT565 is safe, how well the body handles it, and how much is needed to work. This is an early-stage study.
For: Systemic Lupus Erythematosus, SLEBulgaria · China · Germany